Physician profile
Chandresh Shah
NPI 1275952178
$5,218.13
in general payments reported to CMS, 2019-2025
10 companies · $788 in 2025
The $788 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.80 · 2020: $265 · 2021: $208 · 2022: $540 · 2023: $2,616 · 2024: $736 · 2025: $788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,859 · Travel and Lodging: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,858.84 |
| Travel and Lodging | $1,282.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,497.32 | 2022-2025 | Indigo System |
| Terumo Medical Corporation | $1,072.45 | 2020-2025 | Azur Cx Detachable, Metacross Otw |
| Inari Medical, INC. | $643.59 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $247.07 | 2020-2025 | General - Embolics, Obsidio |
| Medtronic, INC. | $233.42 | 2022-2024 | Abre, Concertotm |
| Stryker Corporation | $226.55 | 2023-2025 | Spinejack, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Argon Medical Devices, INC. | $128.85 | 2022-2025 | Clot Management |
| Trisalus Life Sciences, INC. | $48.91 | 2024-2025 | Trinav Infusion System |
| Angiodynamics, INC. | $33.24 | 2021-2023 | Solero |
| Teleflex LLC | $21.93 | 2023 | Arrow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandresh Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.